Of the top 10 largest markets for pharmaceuticals worldwide, the US continues to lead by a widening margin. Recent important growth in China and Japan retain both countries in second and third position in the ranking, respectively, but both countries saw a decline in the market share in 2016. A new entrant in the top 10 ranking is Venezuela, despite profound economic difficulties and challenges in healthcare. The other leading markets are much more closely grouped with less change in overall sales.
IMS Health estimates sales through all distribution channels in all countries, whether these channels are audited by IMS Health or not. These estimates are intended to include both prescription and most non-prescription products and are provided in millions of US dollars (current values) at list prices.